UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000010055
Receipt number R000010954
Scientific Title Phase II study evaluating the efficacy and safety of the Bevacizumab / Docetaxel maintenance therapy beyond stable disease in patients with advanced relapsed non-squamous NSCLC who received Bevacizumab / pemetrexed / platinum induction therapy
Date of disclosure of the study information 2013/02/18
Last modified on 2013/02/17 00:00:20

No. Disposal Last modified on Item of update
1 Insert 2013/02/17 00:03:14